rs183712582
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001127222.2(CACNA1A):c.3882+10G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,597,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000010 ( 0 hom. )
Consequence
CACNA1A
NM_001127222.2 intron
NM_001127222.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.410
Publications
0 publications found
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
- episodic ataxia type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- developmental and epileptic encephalopathy, 42Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- migraine, familial hemiplegic, 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia type 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- benign paroxysmal torticollis of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial or sporadic hemiplegic migraineInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-13277059-C-G is Benign according to our data. Variant chr19-13277059-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 542845.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 15 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.3882+10G>C | intron_variant | Intron 23 of 46 | 1 | NM_001127222.2 | ENSP00000353362.5 | |||
CACNA1A | ENST00000638029.1 | c.3894+10G>C | intron_variant | Intron 23 of 47 | 5 | ENSP00000489829.1 | ||||
CACNA1A | ENST00000573710.7 | c.3888+10G>C | intron_variant | Intron 23 of 46 | 5 | ENSP00000460092.3 | ||||
CACNA1A | ENST00000635727.1 | c.3885+10G>C | intron_variant | Intron 23 of 46 | 5 | ENSP00000490001.1 | ||||
CACNA1A | ENST00000637769.1 | c.3885+10G>C | intron_variant | Intron 23 of 46 | 1 | ENSP00000489778.1 | ||||
CACNA1A | ENST00000636012.1 | c.3885+10G>C | intron_variant | Intron 23 of 45 | 5 | ENSP00000490223.1 | ||||
CACNA1A | ENST00000637736.1 | c.3744+10G>C | intron_variant | Intron 22 of 45 | 5 | ENSP00000489861.1 | ||||
CACNA1A | ENST00000636389.1 | c.3885+10G>C | intron_variant | Intron 23 of 46 | 5 | ENSP00000489992.1 | ||||
CACNA1A | ENST00000637432.1 | c.3894+10G>C | intron_variant | Intron 23 of 47 | 5 | ENSP00000490617.1 | ||||
CACNA1A | ENST00000636549.1 | c.3885+10G>C | intron_variant | Intron 23 of 47 | 5 | ENSP00000490578.1 | ||||
CACNA1A | ENST00000637927.1 | c.3888+10G>C | intron_variant | Intron 23 of 46 | 5 | ENSP00000489715.1 | ||||
CACNA1A | ENST00000635895.1 | c.3885+10G>C | intron_variant | Intron 23 of 46 | 5 | ENSP00000490323.1 | ||||
CACNA1A | ENST00000638009.2 | c.3885+10G>C | intron_variant | Intron 23 of 46 | 1 | ENSP00000489913.1 | ||||
CACNA1A | ENST00000637276.1 | c.3885+10G>C | intron_variant | Intron 23 of 45 | 5 | ENSP00000489777.1 | ||||
CACNA1A | ENST00000636768.2 | n.3885+10G>C | intron_variant | Intron 23 of 44 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000713789.1 | n.3882+10G>C | intron_variant | Intron 23 of 46 | ENSP00000519091.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
152108
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000524 AC: 13AN: 248260 AF XY: 0.0000445 show subpopulations
GnomAD2 exomes
AF:
AC:
13
AN:
248260
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000104 AC: 15AN: 1444892Hom.: 0 Cov.: 27 AF XY: 0.00000972 AC XY: 7AN XY: 719936 show subpopulations
GnomAD4 exome
AF:
AC:
15
AN:
1444892
Hom.:
Cov.:
27
AF XY:
AC XY:
7
AN XY:
719936
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33194
American (AMR)
AF:
AC:
15
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26008
East Asian (EAS)
AF:
AC:
0
AN:
39618
South Asian (SAS)
AF:
AC:
0
AN:
85908
European-Finnish (FIN)
AF:
AC:
0
AN:
53150
Middle Eastern (MID)
AF:
AC:
0
AN:
5720
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1096888
Other (OTH)
AF:
AC:
0
AN:
59750
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.412
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74298 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
152108
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74298
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41404
American (AMR)
AF:
AC:
2
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68036
Other (OTH)
AF:
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.600
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Nov 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.